Biocompatibility of icodextrin.
Cooker
Laurinda A
LA
Renal Division Research, Baxter Healthcare Corporation, McGaw Park, Illinois 60085-6730, USA. Laurie_Cooker@baxter.com
Holmes
Clifford J
CJ
Hoff
Catherine M
CM
D015314:Dialysis Solutions / Q000009:adverse effects* / Q000627:therapeutic use*; D005936:Glucans / Q000009:adverse effects* / Q000627:therapeutic use*; D005947:Glucose / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use*; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006801:Humans; D000077607:Icodextrin; D009997:Osmotic Pressure; D010530:Peritoneal Dialysis; D010537:Peritoneum / Q000378:metabolism
D015314:Dialysis Solutions; D005936:Glucans; D017127:Glycation End Products, Advanced; D000077607:Icodextrin; D005947:Glucose